Antitumor effects and anticancer applications of bisphosphonates.
about
Discovery of Novel Allosteric Non-Bisphosphonate Inhibitors of Farnesyl Pyrophosphate Synthase by Integrated Lead FindingCurrent management of aneurysmal bone cystsThree cases of bone metastases in patients with gastrointestinal stromal tumors.Depletion of cutaneous macrophages and dendritic cells promotes growth of basal cell carcinoma in mice.Bisphosphonamidate clodronate prodrug exhibits potent anticancer activity in non-small-cell lung cancer cellsZoledronic acid and atorvastatin inhibit αvβ3-mediated adhesion of breast cancer cellsMechanisms of the antitumor activity of human Vγ9Vδ2 T cells in combination with zoledronic acid in a preclinical model of neuroblastoma.Monocytes and macrophages in cancer: development and functionsA virtual approach to evaluate therapies for management of multiple myeloma induced bone diseaseCan the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer?Bisphosphonamidate clodronate prodrug exhibits selective cytotoxic activity against melanoma cell lines.Macrophages in cancer and infectious diseases: the 'good' and the 'bad'.On the Reaction of Carbonyl Diphosphonic Acid with Hydroxylamine and O-alkylhydroxylamines: Unexpected Degradation of P-C-P Bridge.Zoledronic acid induces apoptosis via stimulating the expressions of ERN1, TLR2, and IRF5 genes in glioma cells.Zoledronic acid induces apoptosis and autophagy in cervical cancer cells.Zoledronic acid and irradiation in oral squamous cell carcinoma.Zoledronic acid and radiation: toxicity, synergy or radiosensitization?Origin and Functions of Tumor-Associated Myeloid Cells (TAMCs).[Characteristics and treatment of bone metastases in 322 cases non-small cell lung cancer: a retrospective study].Models for anti-tumor activity of bisphosphonates using refined topochemical descriptors.
P2860
Q27702178-27FC4895-BFE5-48B1-A06F-F341F602A249Q28068662-FF23E0EB-34DF-4B76-9CB5-BE9732A70964Q35093218-7A5772CA-7883-4F65-909E-E5D74E1C892CQ35137682-D5C78487-F333-4DB6-89C0-1B4A0CE0FADDQ35285026-FC78EA5F-2272-4E77-9957-B7A086058888Q36491662-9FCA8703-0AD9-40C4-8268-AD57DDE94D6EQ36883879-08E654E8-5FF5-4A44-BCF6-C154436FC2E3Q37028772-596078A4-7093-45B8-8C6E-2CDC37D90598Q37185494-13D7373D-2A27-40D0-B27F-6597969EF891Q37301804-2C0D50B7-D050-4F3E-B77A-9BE0F117E823Q37623726-3D1D00CB-6323-492C-9ACF-5D315DEDEFAEQ37945300-16E2C01F-3057-4426-9A2F-FF5551C0F033Q38712171-640CC05B-680B-41C9-A7EA-629808FCFD19Q38813588-5D0A315E-219E-4E28-9D17-6EA33794A23BQ38964271-B91B694A-1D8E-48D5-99DE-40F5D9AC7B2AQ38971985-16012F0D-FC93-43E8-AC67-43CF62BFD1D5Q39188074-620CFA9C-F1C1-48E8-9F46-AAF6278E7DACQ41910192-C294F8AA-700F-45E7-AE7D-90FBEDF76FC8Q53049778-F41223B8-D1A4-4D98-B78B-9A06B56849FEQ53743085-56CE1F29-5E24-4327-987F-D653C13B664B
P2860
Antitumor effects and anticancer applications of bisphosphonates.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Antitumor effects and anticancer applications of bisphosphonates.
@en
Antitumor effects and anticancer applications of bisphosphonates.
@nl
type
label
Antitumor effects and anticancer applications of bisphosphonates.
@en
Antitumor effects and anticancer applications of bisphosphonates.
@nl
prefLabel
Antitumor effects and anticancer applications of bisphosphonates.
@en
Antitumor effects and anticancer applications of bisphosphonates.
@nl
P1433
P1476
Antitumor effects and anticancer applications of bisphosphonates.
@en
P2093
Allan Lipton
Gareth Morgan
P304
P356
10.1053/J.SEMINONCOL.2010.10.005
P478
37 Suppl 2
P577
2010-10-01T00:00:00Z